PubRank
Search
About
Run-Xuan Shao
Author PubWeight™ 20.24
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
J Hepatol
2010
1.64
2
HIV increases HCV replication in a TGF-beta1-dependent manner.
Gastroenterology
2008
1.60
3
Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.
Gastroenterology
2010
1.51
4
Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
Liver Int
2008
1.40
5
Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
Liver Int
2010
1.22
6
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
Hepatology
2008
1.17
7
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
J Hepatol
2006
1.14
8
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Clin Cancer Res
2006
1.12
9
Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
J Hepatol
2009
0.98
10
ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.
PLoS One
2012
0.98
11
HIV infection increases HCV-induced hepatocyte apoptosis.
J Hepatol
2010
0.95
12
Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation.
Hepatology
2004
0.95
13
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication.
Liver Int
2009
0.89
14
Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Hepatology
2005
0.89
15
Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A.
Hepatol Int
2007
0.84
16
The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.
J Hepatol
2013
0.81
17
Vitamin K2 binds 17beta-hydroxysteroid dehydrogenase 4 and modulates estrogen metabolism.
Life Sci
2005
0.76
18
No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell lines.
J Gastroenterol
2005
0.76
19
Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Liver Int
2009
0.76